🇺🇸 CINRYZE 500 in United States

6 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 6

Most-reported reactions

1. Dizziness — 1 report (16.67%)
2. Dyspnoea — 1 report (16.67%)
3. Pallor — 1 report (16.67%)
4. Panic Attack — 1 report (16.67%)
5. Pharyngeal Oedema — 1 report (16.67%)
6. Throat Tightness — 1 report (16.67%)

Source database →

Frequently asked questions

Is CINRYZE 500 approved in United States?

CINRYZE 500 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for CINRYZE 500 in United States?

Shire is the originator. The local marketing authorisation holder may differ — check the official source linked above.